Understanding hypoparathyroidism as a disease of broad functional deficiency
Hypoparathyroidism (HypoPT) is a rare disease defined by undetectable, low, or inappropriately normal parathyroid hormone (PTH) concentrations in the presence of hypocalcemia. Calcium and active vitamin D are often used for the treatment of HypoPT but do not address the underlying lack of physiological PTH activity. In this review, we discuss how the chronic inadequacy of PTH leads to broad functional consequences. This functional deficiency results in a wide spectrum of symptoms, impaired functioning and quality of life, and significant economic and healthcare costs. We consider how kidney complications could develop in patients with HypoPT and highlight recent developments in understanding the heterogeneity of bone health in HypoPT, including certain patient populations.
Authors
- Jean‐Philippe Bertocchio (ORCID: https://orcid.org/0000-0002-4104-702X)
- Ellen Colman
- Maria Luisa Brandi (ORCID: https://orcid.org/0000-0002-8741-0592)
- Lars Rejnmark (ORCID: https://orcid.org/0000-0002-2152-4247)
- István Takács (ORCID: https://orcid.org/0000-0002-7810-4833)
- Aliya Khan
Institutions
- Semmelweis University (HU)
- Santa Maria Nuova Hospital (IT)
- Aarhus University Hospital (DK)
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Pitié-Salpêtrière Hospital (FR)
- AstraZeneca (United States) (US)
- Alexion Pharma (Switzerland) (CH)
- McMaster University (CA)
Publication Details
- Journal
- Trends in Endocrinology and Metabolism
- Published
- 2026-04-01
- DOI
- https://doi.org/10.1016/j.tem.2026.03.009
- Primary Topic
- Thyroid and Parathyroid Surgery
- Type
- article
- Field-Weighted Citation Impact
- 0.00